Aandeel BDSI BIODELIVERY SCIENCES INTERNATIONAL, INC.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren
Inactief instrument

Andere talen BioDelivery Sciences International, Inc.

Aandelen

BDSI

US09060J1060

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!
Gratis inschrijven
Tranche Update on BioDelivery Sciences International, Inc.'s Equity Buyback Plan announced on November 4, 2020.
Collegium Pharmaceutical Completes Acquisition of BioDelivery Sciences
BioDelivery Sciences International : Termination of a Material Definitive Agreement - Form 8-K
BIODELIVERY SCIENCES INTERNATIONAL INC : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
Collegium Completes the Acquisition of BDSI
BioDelivery Sciences International, Inc.(NasdaqGS:BDSI) dropped from NASDAQ Composite Index
BioDelivery Sciences International, Inc.(NasdaqGS:BDSI) dropped from S&P Global BMI Index
BioDelivery Sciences International, Inc.(NasdaqGS:BDSI) dropped from S&P TMI Index
Collegium Pharmaceutical, Inc. completed the acquisition of BioDelivery Sciences International, Inc. for approximately $670 million.
BioDelivery Sciences International, Inc.(NasdaqGS:BDSI) dropped from NASDAQ Biotechnology Index
BIODELIVERY SCIENCES INTERNATIONAL INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
Tranche Update on BioDelivery Sciences International, Inc.'s Equity Buyback Plan announced on November 4, 2020.
BioDelivery Sciences International, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
BioDelivery Sciences International Launches Oral Solution for Acute Treatment of Migraine in US
BioDelivery Sciences International Announces ELYXYB™ is Now Available in the U.S. for the Acute Treatment of Migraine
Biodelivery Sciences International Announces ELYXYB Is Now Available in the U.S. for the Acute Treatment of Migraine
BioDelivery Sciences International : Material Definitive Agreement - Form 8-K/A
BIODELIVERY SCIENCES INTERNATIONAL INC Entry into a Material Definitive Agreement, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K/A)
Bam Bam Resources (NPEZF) could be well positioned to take advantage of the World Copper shortage
Collegium Pharmaceutical to Acquire BioDelivery Sciences in All-Cash Deal; Shares Jump
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers BDSI
  4. Nieuws BioDelivery Sciences International, Inc.
  5. Andere talen